McKesson (MEX:MCK) Tariff Resilience Score: 5/10 (As of Jul. 05, 2026)


MEX:MCK McKesson Corp MEX:MCK
75 GF Score
Price MXN13,691.02
GF Value MXN13,807.16
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is McKesson Tariff Resilience Score?

McKesson MEX:MCK 75 Tariff Resilience Score is 5 as of Jul. 05, 2026. GuruFocus rates MEX:MCK with a GF Score™ of 75/100 and a GF Value™ of MXN13,807.16 (Fairly Valued). The stock has 2 warning signs investors should review. Among 119 Medical Distribution companies, McKesson ranks better than 92.44% on this metric.

McKesson has the Tariff Resilience Score of 5, which implies that the company might have Average Resilient.

McKesson has McKesson, a healthcare distributor, faces moderate tariff risks due to its global supply chain for pharmaceuticals and medical products. Past tariffs have impacted costs, but the company has some pricing power and alternative sourcing options. The healthcare industry has specific exemptions that offer some protection.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes McKesson might have Average Resilient.

McKesson  (MEX:MCK) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

McKesson Tariff Resilience Score Related Terms

MEX:MCK vs CAH, COR, HSIC: Tariff Resilience Score Comparison

For the Medical Distribution subindustry, McKesson's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

McKesson Tariff Resilience Score vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, McKesson's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where McKesson's Tariff Resilience Score falls into.


MEX:MCK
75GF Score
McKesson Corp MEX:MCK
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 5 mean?
McKesson (MEX:MCK) has a Tariff Resilience Score of 5 as of Jul. 05, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, McKesson ranks #9 out of 119 companies in the Medical Distribution industry, placing it in the top 7.6%.
Is McKesson's Tariff Resilience Score too high?
McKesson's current Tariff Resilience Score is 5. Based on the distribution chart, McKesson ranks #9 out of 119 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, McKesson has a GF Score™ of 75/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does McKesson's Tariff Resilience Score compare to CAH and COR?
According to the Medical Distribution industry distribution chart, McKesson ranks #9 out of 119 companies for Tariff Resilience Score. This places McKesson in the top 8% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Medical Distribution company?
A good Tariff Resilience Score depends on the Medical Distribution industry context. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. McKesson's current Tariff Resilience Score is 5. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is McKesson stock overvalued right now?
Based on GuruFocus' analysis, McKesson (MEX:MCK) is currently considered Fairly Valued. The stock's GF Value™ is MXN13,807.16, compared to a current price of MXN13,691.02 — trading 0.8% below its estimated fair value. The current Tariff Resilience Score is 5. McKesson's overall GF Score™ is 75/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For McKesson (MEX:MCK), the current Tariff Resilience Score is 5 as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is McKesson (MEX:MCK) Overvalued in 2026?

Based on GuruFocus' analysis, McKesson stock appears to be undervalued. The current stock price of MXN13,691.02 is trading 0.8% below its estimated GF Value™ of MXN13,807.16. GuruFocus considers McKesson to be Fairly Valued.

Key valuation signals for MEX:MCK:

  • Tariff Resilience Score: 5
  • GF Value™: MXN13,807.16 vs. price of MXN13,691.02 (0.8% below fair value)
  • GF Score™: 75/100 with 2 warning signs

No single metric tells the full story. See the MEX:MCK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

McKesson Business Description

Address 6555 State Highway 161, Irving, TX, USA, 75039
McKesson is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
75GF Score

Get the complete analysis for MEX:MCK

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN13,691.02
Price
MXN13,807.16
GF Value